With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.17217-57-1,4,4′-Dimethoxy-2,2′-bipyridine,as a common compound, the synthetic route is as follows.
General procedure: [Cu-(MeCN)4]PF6 (74 mg, 0.20 mmol) was added to TolBINAP(135 mg, 0.20 mmol) in 2 mL CH2Cl2. Then, bpy (31 mg, 0.20mmol) was added. The yellow reaction mixture was stirred for90 minutes at room temperature. Diethyl ether (25 mL) wasadded to the solution to precipitate the product as a yellowsolid, which was filtered and dried in vacuum.
17217-57-1, The synthetic route of 17217-57-1 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Nishikawa, Michihiro; Tsuji, Masakata; Ohishi, Tomoyuki; Tsubomura, Taro; Bulletin of the Chemical Society of Japan; vol. 90; 7; (2017); p. 798 – 800;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI